"Trying to make medications more affordable is important, but if Washington isn't careful, we might leave innovation behind." This is the message the Pharmaceutical Research and Manufacturers of America (PhRMA) heard from Amy, a Voters for Cures advocate from South Carolina who reminds us what's at stake in the broader public policy debate around medical innovation, access and affordability.
This program provides one-year funding to organizations executing programs related to SBIR/STTR outreach, technical assistance, or financial support. As a way to help inform these proposals, SSTI has updated the data from a January Useful Stats article on NIH SBIR/STTR success rates to include the most recent year available, FY 2018.
Unjustified and outsized verdicts harm society by discouraging investment in innovative products. Researchers at the University of Chicago Booth School of Business and Tilburg University recently aggregated data from more than 40,000 lawsuits filed between 1996 and 2011 and found that “frivolous lawsuits tended to focus on highly innovative businesses,” costing the average defendants $1.1 million each year.
Prosperity Capitalism is my term for when free enterprise, free markets and democracy thrive so does innovation. Prosperity results when capitalism is enabled by free markets, access to capital, talent and tools. Low regulation is part of the equation, In fact I could argue that the heart of Prosperity Capitalism are democratic values that drive invention, risk and reward.
Measurements are key to scientific and technological innovation. It’s like a field of dreams: Better measurements always find useful applications. Proving this credo, NIST's nearly 120 years of research to advance measurement science, standards and technology have had significant impacts on American innovation and quality of life.
Once the war ended, American soldiers brought home that innovative spirit that has propelled our economy in the years since World War II. It makes our market-based system the envy of the world. In the intervening 75 years, other countries that cast off their oppressive, totalitarian regimes studied the United States as the economic model. They not only looked at Washington companies such as Boeing, Microsoft and SEL for guidance, but our education as well.
Since our country’s founding, the U.S. patent system has been one of the unsung heroes of America’s success story. Patents are based on a simple concept: that American inventors, entrepreneurs and companies whose hard work and expertise lead to a new invention deserve to reap the benefits of their work for a limited time.
The U.S. must continue to develop and support an innovation economy that, “collaborates with allies and partners, improves STEM education, draws on an advanced technical workforce, and invests in early-stage research and development,” according to the latest U.S. National Security Strategy (NSS).4 Further, the NSS asserts that the nation must continue to be the destination of choice for the “innovative and the inventive, the brilliant and the bold.”
NIST launched this initiative to bring together communities and technology innovators to collaborate on smart city solutions that would be accessible to all because of their reliance on standards-based approaches. The challenge fosters the creation of "action clusters" -- partnerships across government, industry and academia -- to address city and community goals in areas such as energy, transportation, security, public health and others.
In a sweeping decision, Judge Lucy Koh has ruled last week that Qualcomm violated the antitrust laws in licensing its 4G digital communications technology in smartphones. “Invent a better mousetrap, and you’ll be rewarded” has long been the motto driving the U.S. innovation economy--from lightbulbs to airplanes to smartphones. Everyone benefits. This is in doubt now.